Euroseas Ltd. Sets Date for the Release of Third Quarter 2024 Results, Conference Call and Webcast
ATHENS, Greece, Nov. 14, 2024 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels […]
Elevai Labs Inc. Reports Financial Results for the Second Fiscal Quarter of 2024 and Provides Business Update
Achieves Robust Financial Performance with 74% Gross Margin and Strategic Public Offering, Bolstering Resources for Continued Growth and Innovation. Elevai […]
Thumzup Accelerates Expansion Across the Greater Los Angeles Area Following Nasdaq Listing
Thumzup begins aggressive expansion in key regions such as Beverly Hills, the San Fernando Valley, West Los Angeles, Hollywood, Pasadena, […]
Mercurity Fintech CEO Highlights Strategic Vision Following Participation in Nasdaq Small-Cap Forum
New York, Nov. 14, 2024 (GLOBE NEWSWIRE) — Mercurity Fintech Holding Inc. (“Mercurity Fintech,” “the Company,” “we,” “us,” “our company,” […]
Beyond Sun Sausage™ Expands to Whole Foods Market
Following a successful initial launch, Beyond Meat’s healthy, flavor-forward plant-based links are debuting at Whole Foods Market stores coast-to-coast Beyond […]
Reading International Reports Third Quarter 2024 Results
Earnings Call Webcast to Discuss Third Quarter Financial ResultsScheduled to Post to Corporate Website on Monday, November 18, 2024 NEW […]
Progyny, Inc. to Present at Jefferies London Healthcare Conference
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health […]
Wix to Participate in a Fireside Chat at the UBS Global Technology and AI Conference
NEW YORK, November 14, 2024 – – Wix.com Ltd. (NASDAQ: WIX), today announced that Wix management will participate in a […]
Palisade Bio CMO Mitch Jones, MD, PhD, to Present at 8th Annual Antifibrotic Drug Development (AFDD) Summit
Presentation to highlight advances in fibrostenotic Crohn’s Disease and the potential of localized PDE4 inhibition Carlsbad, CA, Nov. 14, 2024 (GLOBE […]
ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year. Incremental Payments […]
